524 related articles for article (PubMed ID: 35054790)
1. Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases.
Shen H; Zhao Z; Zhao Z; Chen Y; Zhang L
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054790
[TBL] [Abstract][Full Text] [Related]
2. Insights into the Mechanisms of Action of
Mruk-Mazurkiewicz H; Kulaszyńska M; Czarnecka W; Podkówka A; Ekstedt N; Zawodny P; Wierzbicka-Woś A; Marlicz W; Skupin B; Stachowska E; Łoniewski I; Skonieczna-Żydecka K
Nutrients; 2024 May; 16(11):. PubMed ID: 38892628
[TBL] [Abstract][Full Text] [Related]
3.
Rodrigues VF; Elias-Oliveira J; Pereira ÍS; Pereira JA; Barbosa SC; Machado MSG; Carlos D
Front Immunol; 2022; 13():934695. PubMed ID: 35874661
[No Abstract] [Full Text] [Related]
4. A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease.
Kanai T; Mikami Y; Hayashi A
J Gastroenterol; 2015 Sep; 50(9):928-39. PubMed ID: 25940150
[TBL] [Abstract][Full Text] [Related]
5. Intestinal dysbiosis: novel mechanisms by which gut microbes trigger and prevent disease.
Underwood MA
Prev Med; 2014 Aug; 65():133-7. PubMed ID: 24857830
[TBL] [Abstract][Full Text] [Related]
6. The protective effect of
Yoshihara T; Oikawa Y; Kato T; Kessoku T; Kobayashi T; Kato S; Misawa N; Ashikari K; Fuyuki A; Ohkubo H; Higurashi T; Tateishi Y; Tanaka Y; Nakajima S; Ohno H; Wada K; Nakajima A
Gut Microbes; 2020 Sep; 11(5):1385-1404. PubMed ID: 32515658
[TBL] [Abstract][Full Text] [Related]
7. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
[TBL] [Abstract][Full Text] [Related]
8. The role of immunomodulators on intestinal barrier homeostasis in experimental models.
Andrade ME; Araújo RS; de Barros PA; Soares AD; Abrantes FA; Generoso Sde V; Fernandes SO; Cardoso VN
Clin Nutr; 2015 Dec; 34(6):1080-7. PubMed ID: 25660317
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of probiotics: recent advances.
Ng SC; Hart AL; Kamm MA; Stagg AJ; Knight SC
Inflamm Bowel Dis; 2009 Feb; 15(2):300-10. PubMed ID: 18626975
[TBL] [Abstract][Full Text] [Related]
10. Lactic Acid Bacteria Mixture Isolated From Wild Pig Alleviated the Gut Inflammation of Mice Challenged by
Zhong Y; Fu D; Deng Z; Tang W; Mao J; Zhu T; Zhang Y; Liu J; Wang H
Front Immunol; 2022; 13():822754. PubMed ID: 35154141
[TBL] [Abstract][Full Text] [Related]
11. The role of
Hasani A; Ebrahimzadeh S; Hemmati F; Khabbaz A; Hasani A; Gholizadeh P
J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34623232
[TBL] [Abstract][Full Text] [Related]
12. [Probiotics: history, definition, requirements and possible therapeutic applications].
Montalto M; Arancio F; Izzi D; Cuoco L; Curigliano V; Manna R; Gasbarrini G
Ann Ital Med Int; 2002; 17(3):157-65. PubMed ID: 12402663
[TBL] [Abstract][Full Text] [Related]
13. The role of
Zheng M; Han R; Yuan Y; Xing Y; Zhang W; Sun Z; Liu Y; Li J; Mao T
Front Immunol; 2022; 13():1089600. PubMed ID: 36685588
[TBL] [Abstract][Full Text] [Related]
14. Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders.
Macchione IG; Lopetuso LR; Ianiro G; Napoli M; Gibiino G; Rizzatti G; Petito V; Gasbarrini A; Scaldaferri F
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8075-8083. PubMed ID: 31599433
[TBL] [Abstract][Full Text] [Related]
15.
Tao R; Zong G; Pan Y; Li H; Cheng P; Deng R; Chen W; Wang A; Xia S; Tang W; Lu Y; Wei Z
mSystems; 2023 Dec; 8(6):e0073223. PubMed ID: 37921463
[TBL] [Abstract][Full Text] [Related]
16. Exploring the influence of the gut microbiota and probiotics on health: a symposium report.
Thomas LV; Ockhuizen T; Suzuki K
Br J Nutr; 2014 Jul; 112 Suppl 1(Suppl 1):S1-18. PubMed ID: 24953670
[TBL] [Abstract][Full Text] [Related]
17. Metabolic regulation mechanism of fucoidan via intestinal microecology in diseases.
Sun T; Xue M; Yang J; Pei Z; Zhang N; Qin K; Liang H
J Sci Food Agric; 2021 Aug; 101(11):4456-4463. PubMed ID: 33682122
[TBL] [Abstract][Full Text] [Related]
18. Next generation probiotics in disease amelioration.
Chang CJ; Lin TL; Tsai YL; Wu TR; Lai WF; Lu CC; Lai HC
J Food Drug Anal; 2019 Jul; 27(3):615-622. PubMed ID: 31324278
[TBL] [Abstract][Full Text] [Related]
19. Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?
Verbeke KA; Boesmans L; Boets E
Proc Nutr Soc; 2014 Nov; 73(4):490-7. PubMed ID: 24969143
[TBL] [Abstract][Full Text] [Related]
20. Dietary supplementation with Clostridium butyricum helps to improve the intestinal barrier function of weaned piglets challenged with enterotoxigenic Escherichia coli K88.
Li HH; Li YP; Zhu Q; Qiao JY; Wang WJ
J Appl Microbiol; 2018 Oct; 125(4):964-975. PubMed ID: 29851202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
